ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis.

K. Yoon, K.-W. Lee, H. Kim, D. Oh, H.-S. Kim, S. Ahn, S. Hong, N.-J. Yi, K.-S. Suh.

Department of Surgery, Seoul National University College of Medicine, Seoul, Jongrogu, Republic of Korea

Meeting: 2017 American Transplant Congress

Abstract number: A74

Keywords: Liver cirrhosis, Recurrence

Session Information

Session Name: Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

Session Type: Poster Session

Date: Saturday, April 29, 2017

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall D1

Introduction: Hepatocellular carcinoma(HCC) has high recurrence rate after liver resection(LR). The recurrence within Milan after LR is only 61- 79% in patient with child A. On the other hand, liver transplantation(LT) has better outcomes even in patient with child A than LR because LT can overcome the tumor and background liver factors. Therefore some authors insisted preemptive LT in patient with high probability of aggressive recurrence with some risk factors.we hypothesis that the according to the background liver and tumor biology, treatment option would be different.Method: We reviewed patient data retrospectively who received LR or LT in Seoul National university hospital. The patient group was divided into two groups according to the platelet count which reflect the degree of the cirrhosis. We performed risk factor analysis using only preoperative risk factors for decision. Platelet count and Child A were used as a background liver factor, and AFP and tumor size and number is used as tumor characteristics. Result: Total 663 patient was included in liver resection group and 210 patient was included in liver transplantation group. We compared overall survival(OS) and recurrence free survival(RFS) between LR group and LT group in each subgroups according to the degree of the cirrhosis. Three risk factors were used which was significant in multivariate analysis, AFP more than 100, the number of tumor is more than 1, the size of tumor is more than 5cm as a tumor factor. If there are no risk factors in no or mild cirrhosis group, RFS, OS was not significantly different in both group. And if there are one risk factors, OS was similar but RFS survival rate is higher in LT group. But if there are 2 risk factors, survival rate is higher in LT group. In second subgroup If there are no risk, overall survival was similar in both group. But if there are 1 risk factors, and 2 risk factors, survival rate is higher in LT group. Conclusion: If the patient with no or mild liver cirrhosis, LR can be performed even the patient have 1 risk factor. But when the patient with moderate to severe cirrhosis resection can be performed without any risk factor. LT have to be considered in patient with 2 risk factors even the mild cirrhotic liver. And If the patient with moderate to severe cirrhosis, even the 1 risk factors, transplantation have to be considered.

CITATION INFORMATION: Yoon K, Lee K.-W, Kim H, Oh D, Kim H.-S, Ahn S, Hong S, Yi N.-J, Suh K.-S. Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yoon K, Lee K-W, Kim H, Oh D, Kim H-S, Ahn S, Hong S, Yi N-J, Suh K-S. Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/which-way-to-go-liver-resection-or-liver-transplantation-for-hepatocellular-carcinoma-in-child-a-liver-cirrhosis/. Accessed May 12, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences